TrialJournal of neurology, neurosurgery, and psychiatry2004

Biological activity of interferon betas in patients with multiple sclerosis is affected by treatment regimen and neutralising antibodies.

A Bertolotto et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.